Axitinib

Axitinib is an oral prescription medication primarily used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer. It is a type of targeted therapy known as a tyrosine kinase inhibitor (TKI).
It is a type of targeted therapy known as a tyrosine kinase inhibitor (TKI).